Our news
-
The UNDER Study opens to recruitment
12 April 2024
-
WISE study opens to recruitment
15 January 2024
-
ROBUST Study Opens to Recruitment
5 January 2024
-
RAMBOH-1 opens to recruitment
4 January 2024
-
MILI opens to recruitment
20 December 2023
Our training sessions
-
Trials Expertise Session: Site Feasibility Questionnaire (SFQ) & Site selection *ONLINE*
Thursday, 16 May 2024, 10am to 11am
-
-
OCTRU Extended Training Bite: Introduction to OCTRU Database Systems
Wednesday, 22 May 2024, 1pm to 3.30pm
Our publications
-
A phase I open-label, dose-escalation study of NUC-3373, a targeted thymidylate synthase inhibitor, in patients with advanced cancer (NuTide:301).
Spiliopoulou P. et al, (2024), J exp clin cancer res, 43
-
Cost-effectiveness analysis of a pragmatic randomized trial evaluating surgical reconstruction versus rehabilitation in patients with long-standing anterior cruciate ligament injury.
Leal J. et al, (2024), Bone joint j, 106-B, 38 - 45
-
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial.
Abhishek A. et al, (2024), Lancet rheumatol, 6, e92 - e104
-
Findings from a pilot randomized trial of spinal decompression alone or spinal decompression plus instrumented fusion.
Beresford-Cleary NJA. et al, (2023), Bone jt open, 4, 573 - 579
-
Effectiveness of nail bed repair in children with or without replacing the fingernail: NINJA multicentre randomized clinical trial.
Jain A. et al, (2023), Br j surg, 110, 432 - 438
Collaborate with us!
We are open for collaborations and welcome your requests at any point.
NIHR CTU SUPPORT
This unit receives National Institute for Health Research CTU Support Funding.
This funding has been awarded to support the unit in developing and supporting NIHR trials.